Views

CrossRef citations to date

Altmetric

Letters to the Editor

Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34⁺ cells is associated with improved survival

Anu Partanena Department of Medicine, Kuopio University Hospital, Kuopio, FinlandCorrespondence[email protected]

Antti Turunena Department of Medicine, Kuopio University Hospital, Kuopio, Finland;b Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

Jaakko Valtolaa Department of Medicine, Kuopio University Hospital, Kuopio, Finland

Marja Pyöräläa Department of Medicine, Kuopio University Hospital, Kuopio, Finland

Kaija Vasalac Department of Oncology, Central Hospital of Central Finland, Jyväskylä, Finland

Outi Kuittinenb Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;d Department of Oncology, Oulu University Hospital, Oulu, Finland;e Department of Oncology, Kuopio University Hospital, Kuopio, Finland

Hanne Kuitunend Department of Oncology, Oulu University Hospital, Oulu, Finland

Karri Penttiläf Department of Medicine, Central Hospital of Savonlinna, Savonlinna, Finland;g Finnish Medicines Agency, Kuopio, Finland

Taru Kuittinena Department of Medicine, Kuopio University Hospital, Kuopio, Finland

Pentti Mäntymaah Eastern Finland Laboratory Centre, Kuopio, Finland

Jukka Pelkonenh Eastern Finland Laboratory Centre, Kuopio, Finland;i Department of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland

Ville Varmavuoj Department of Medicine, Kymenlaakso Central Hospital, Kotka, Finland

Esa Jantunena Department of Medicine, Kuopio University Hospital, Kuopio, Finland;b Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;k Siunsote-Department of Medicine, Hospital District of North Karelia, Joensuu, Finland

show all

Click to increase image sizeClick to decrease image size

Acknowledgments

Tuomas Selander M.Sc is acknowledged for statistical guidance, Antti Ropponen for analyses by flow cytometry and David Laaksonen M.D., Ph.D. for linguistic revision.

Disclosure statement

Dr. Partanen reports honoraria from Behring and Abbvie and has participated in Scientific Advisory Board meetings organized by Abbvie and Takeda. Dr. Valtola reports honoraria from Amgen, Janssen-Cilag, and Sanofi. Dr. Varmavuo reports consultancy fees from Abbvie, Amgen, Celgene, Janssen-Cilag, Roche, and Sanofi. Dr. Jantunen reports honoraria from Amgen and Sanofi and has participated in Scientific Advisory Board meetings organized by Amgen, Takeda, and TEVA. The other authors declare no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34⁺ cells is associated with improved survival

Information for

Open access

Opportunities

Help and information

Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival

Acknowledgments

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature

Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34⁺ cells is associated with improved survival